KIRKLAND, QC, April 5, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex" or the "Company") is pleased to announce the voting results from its Annual General and Special Meeting of shareholders (the "Meeting") held today in Kirkland, Quebec. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 8,017,627 representing 63.83% of the Company's issued and outstanding shares.
All the matters put forward before shareholders for consideration and approval, as set out in the Company's Management Information Circular dated February 28, 2019, were approved by 100% of the votes cast at the Meeting, which matters included: (1) the election of Steve Saviuk, Helen Saviuk, Ronald Perry and Wynn Rimstad as directors of the Company for the next year; (ii) the appointment of MNP LLP as auditors of the Company until the next annual meeting; (iii) the ratification, confirmation and approval of the sale by the Company of shares of Valeo Pharma Inc. ("Valeo") and Ortho Regenerative Technologies Inc. to certain officers of Valeo and to certain officers and directors of the Company; and (iv) the ratification confirmation and approval of the loans by the Company to certain officers of Valeo and to certain officers and directors of the Company. The related party transactions in (iii) and (iv) above are further described in the Company's Management Information Circular dated February 28, 2019 which can be found on www.sedar.com under the Company's SEDAR profile.
Caution regarding forward-looking statements
This news release may contain certain forward-looking statements regarding the Company's expectations for future events. Such expectations are based on certain assumptions that are founded on currently available information. If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this press release. Factors that could cause actual results to differ include, amongst others, uncertainty as to the final result and other risks. The Company disclaims any intention or obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise, other than as required by security laws.
About Manitex Capital Inc.
Manitex Capital Inc. invests in promising emerging companies in diversified sectors including life sciences, cleantech and sustainable products/technologies. Manitex provides its portfolio companies with specialized corporate finance and advisory services including corporate strategy, mergers and acquisitions, public markets access and financing. Common shares of the Company are listed on the TSX Venture Exchange, under trading symbol MNX.V.
TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
SOURCE Manitex Capital Inc.
For further information: Manitex Capital Inc., Steve Saviuk, Chairman and CEO, Tel.: 514-694-0150, firstname.lastname@example.org